LOS ANGELES--(BUSINESS WIRE)--Kythera Biopharmaceuticals, Inc. (“Kythera”) announced today the appointment of John W. Smither as Chief Financial Officer. Smither will be responsible for all financial and administrative aspects of the company including financing, business planning and budgeting, tax and accounting and treasury.
